---
layout: default
title: Exploring Protein Language Model Architecture-Induced Biases for Antibody Comprehension
---

# Exploring Protein Language Model Architecture-Induced Biases for Antibody Comprehension

**arXiv**: [2512.09894v1](https://arxiv.org/abs/2512.09894) | [PDF](https://arxiv.org/pdf/2512.09894.pdf)

**ä½œè€…**: Mengren, Liu, Yixiang Zhang, Yiming, Zhang

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æŽ¢ç´¢è›‹ç™½è´¨è¯­è¨€æ¨¡åž‹æž¶æž„è¯±å¯¼çš„åè§ä»¥æå‡æŠ—ä½“ç†è§£èƒ½åŠ›**

**å…³é”®è¯**: `è›‹ç™½è´¨è¯­è¨€æ¨¡åž‹` `æŠ—ä½“ç†è§£` `æž¶æž„åè§` `æ³¨æ„åŠ›å½’å› åˆ†æž` `è®¡ç®—æŠ—ä½“è®¾è®¡`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šä¸åŒè›‹ç™½è´¨è¯­è¨€æ¨¡åž‹æž¶æž„å¦‚ä½•å½±å“æŠ—ä½“ç‰¹å¼‚æ€§ç”Ÿç‰©ç‰¹å¾çš„æ•èŽ·èƒ½åŠ›
2. æ–¹æ³•è¦ç‚¹ï¼šç³»ç»Ÿè¯„ä¼°AntiBERTaã€BioBERTã€ESM2å’ŒGPT-2åœ¨æŠ—ä½“é¶æ ‡ç‰¹å¼‚æ€§é¢„æµ‹ä»»åŠ¡ä¸­çš„è¡¨çŽ°
3. å®žéªŒæˆ–æ•ˆæžœï¼šé€šè¿‡æ³¨æ„åŠ›å½’å› åˆ†æžæ­ç¤ºæ¨¡åž‹åœ¨VåŸºå› ä½¿ç”¨ã€ä½“ç»†èƒžè¶…çªå˜å’ŒåŒç§åž‹ä¿¡æ¯ä¸Šçš„åè§

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Recent advances in protein language models (PLMs) have demonstrated remarkable capabilities in understanding protein sequences. However, the extent to which different model architectures capture antibody-specific biological properties remains unexplored. In this work, we systematically investigate how architectural choices in PLMs influence their ability to comprehend antibody sequence characteristics and functions. We evaluate three state-of-the-art PLMs-AntiBERTa, BioBERT, and ESM2--against a general-purpose language model (GPT-2) baseline on antibody target specificity prediction tasks. Our results demonstrate that while all PLMs achieve high classification accuracy, they exhibit distinct biases in capturing biological features such as V gene usage, somatic hypermutation patterns, and isotype information. Through attention attribution analysis, we show that antibody-specific models like AntiBERTa naturally learn to focus on complementarity-determining regions (CDRs), while general protein models benefit significantly from explicit CDR-focused training strategies. These findings provide insights into the relationship between model architecture and biological feature extraction, offering valuable guidance for future PLM development in computational antibody design.

